1. Home
  2. TECX vs PDLB Comparison

TECX vs PDLB Comparison

Compare TECX & PDLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$20.50

Market Cap

413.3M

Sector

N/A

ML Signal

N/A

Logo Ponce Financial Group Inc.

PDLB

Ponce Financial Group Inc.

N/A

Current Price

$21.04

Market Cap

487.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
TECX
PDLB
Founded
2019
1960
Country
United States
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
413.3M
487.9M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
TECX
PDLB
Price
$20.50
$21.04
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
★ $71.00
N/A
AVG Volume (30 Days)
★ 158.1K
121.5K
Earning Date
11-05-2026
10-26-2026
Dividend Yield
N/A
N/A
EPS Growth
40.70
★ 160.87
EPS
N/A
★ 1.47
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$14.57
Revenue Growth
N/A
N/A
52 Week Low
$16.77
$15.18
52 Week High
$39.53
$22.93

Technical Indicators

Market Signals
Indicator
TECX
PDLB
Relative Strength Index (RSI) 44.54 43.13
Support Level $20.52 $19.75
Resistance Level $22.95 $22.83
Average True Range (ATR) 1.29 0.55
MACD 0.19 -0.15
Stochastic Oscillator 44.43 8.33

Price Performance

Historical Comparison
TECX
PDLB

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

Share on Social Networks: